NASDAQ:LFCR Lifecore Biomedical Q1 2027 Earnings Results & Report $6.40 -0.01 (-0.08%) As of 12:20 PM Eastern This is a fair market value price provided by Massive. Learn more. Lifecore Biomedical missed analyst expectations on both earnings and revenue in its Q1 2027 results, released November 4, 2026. The company reported EPS of -$1.08 versus the -$0.2975 consensus estimate, while revenue of $25.32 million fell short of the $25.57 million estimate by $249.00 thousand. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2027Report DateNovember 4, 2026TimeBefore Market OpensConference Call7:00 AM ET Lifecore Biomedical EPS ResultsActual EPS-$1.08Consensus EPS -$0.2975Beat/MissMissed by -$0.7825One Year Ago EPSN/AEPS Beat Rate2 of last 8 quartersLifecore Biomedical Revenue ResultsActual Revenue$25.32 millionExpected Revenue$25.57 millionBeat/MissMissed by -$249.00 thousandYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Lifecore Biomedical Q1 2027 Earnings FAQ Did Lifecore Biomedical beat earnings estimates for Q1 2027? Lifecore Biomedical (NASDAQ:LFCR) reported earnings of -$1.08 per share for Q1 2027, missing the consensus estimate of -$0.2975. The report was announced on Wednesday, November 4, 2026. What was Lifecore Biomedical's revenue for Q1 2027? Lifecore Biomedical reported revenue of $25.32 million for Q1 2027, against a consensus estimate of $25.57 million. Lifecore Biomedical Earnings HeadlinesLifecore Biomedical Inc.November 12 at 8:07 PM | marketwatch.comBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR)November 11 at 11:05 AM | globenewswire.comMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community before the big move happened. Now, I'm making my next big call. It's a coin under $1.00 that most investors have never heard of. But the world's largest bank is already building on it. It has a deflationary burn mechanism tied directly to institutional usage. With Bitcoin well off its highs and fear still hanging over the market, this is the exact environment where my biggest winners have been found.November 13 at 1:00 AM | Crypto 101 Media (Ad)Lifecore's Q3 Loss Widens To $40 Mln As New PPQ Contract GainedNovember 5, 2026 | rttnews.comLifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate UpdateNovember 4, 2026 | markets.businessinsider.comLifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate UpdateNovember 4, 2026 | globenewswire.comSee More Lifecore Biomedical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Lifecore Biomedical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lifecore Biomedical and other key companies, straight to your email. Email Address About Lifecore BiomedicalLifecore Biomedical (NASDAQ:LFCR) is a contract development and manufacturing organization (CDMO) focused on sterile injectable pharmaceutical products. The company works with customers on product development, formulation, analytical testing, regulatory support and commercial-scale manufacturing, including fill-finish services. Lifecore also develops and manufactures hyaluronic acid, a biopolymer used in medical products and other applications. Its capabilities support products in areas such as ophthalmology and orthopedics, as well as pharmaceutical and veterinary uses. Based in Chaska, Minnesota, Lifecore serves pharmaceutical and medical technology companies in the United States and internationally. The business has a history in hyaluronic acid production and has expanded its role as a CDMO serving customers from development through commercial manufacturing.View Lifecore Biomedical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Costco's Record $30 Dividend Shows Just How Strong Its Cash Machine IsThese 3 Stocks Have Bought Back Billions, But Which Offers the Best Value?Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-OffSix Flags Lost $366 Million in Q3—Its Insiders Just Went ShoppingGolden Dome’s $185 Billion Question: Who Actually Gets Paid?3 Pharmaceutical Stocks That Offer Safety and GrowthFirefly Aerospace Lights Up a High-Risk Space Opportunity Upcoming Earnings Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)PDD (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
